Table 4.

Patient preference (per patient analysis)

Baseline prostaglandin analog	n	Preferred previous therapy	Preferred travoprost BAK-free	p-value
Latanoprost	476	25.4%	74.6%	<0.0001
Bimatoprost	215	32.6%	67.4%	<0.0001
Combined	691	27.6%	72.4%	<0.0001